KENNEWICK, Wash., Oct. 26, 2007 (PRIME NEWSWIRE) -- Advanced Medical Isotope Corporation (AMIC) (Pink Sheets:ADMD) of Kennewick, WA today announced that Marishka Pilch will serve as International Marketing Director effective immediately.
Pilch has extensive healthcare, sales and marketing experience. In 2004, she founded PET2Market (see www.pet2market.com), a consulting firm specializing in marketing and clinical education for PET (positron emission tomography) imaging centers. Prior positions for Pilch included marketing and customer support at Alliance Imaging, a national provider of diagnostic imaging services.
"Marishka's strong experience in diagnostic imaging and PET marketing make her a perfect fit in joining the Advanced Medical Isotope's management team," stated James C. Katzaroff, president. "Her extensive background in marketing and client relationship management with healthcare facilities matches AMIC's needs."
"I am thrilled to join Advanced Medical Isotope Corporation and the excellent management team," stated Pilch. "I am looking forward to making significant contributions to the growth of Advanced Medical Isotope Corporation."
About AMIC
Advanced Medical Isotope Corporation is engaged in the development of advanced production systems and processes for bringing previously unavailable medical isotopes to the marketplace and advancing systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques. Advanced Medical Isotope Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers. For more information, please visit www.isotopia.us
Forward-Looking Statements
Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the company's ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including but not limited to, timely developments and acceptance of new products, the impact of competitive products and pricing, the timely development and release of products by suppliers, and other risks.